Crown Castle International Corp. Stock Outperforms Market On Strong Trading Day

argenx SE

Change company Symbol lookup

Select an option...

ARGX argenx SE

ENZC Enzolytics Inc

GREE Greenidge Generation Holdings Inc

MLM Martin Marietta Materials Inc

ERESW East Resources Acquisition Equity Warrant Exp 1st July 2027 *W EXP 07/01/2027

NRAC Noble Rock Acquisition Corp

DCGO DocGo Inc

VELOW Velocity Acquisition Equity Warrant Exp 24 Feb 2028 *W EXP 02/24/2028

MRC MRC Global Inc

BAC Bank of America Corp

Health Care : Biotechnology | Mid Cap Growth
Based in Netherlands

Company profile

argenx SE, formerly arGEN X BV, is the Netherlands-based biopharmaceutical company. It creates and develops a pipeline of differentiated antibody therapeutics using its discovery platform, Simple Antibody, which exploits characteristics of the llama immune system. The Company develops a pipeline of antibody therapeutics focused on cancer and autoimmune indications. It includes: ARGX-110, an antibody for heme malignancies and solid tumors, which modulates functions of tumor such as cell proliferation and survival; ARGX-111, an antagonist of c-Met, a receptor tyrosine kinase involved in cell proliferation, angiogenesis and metastasis in multiple solid tumors; ARGX-112, an antigen which targets atopic dermatitis by neutralization of IL-20 and IL-22 (interleukin) mediated signaling through blockade of their common receptor, among others.

Crown Castle International Corp. Stock Outperforms Market On Strong Trading Day

4:43 pm ET December 29, 2021 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Crown Castle International Corp. (CCI) inched 0.48% higher to $207.30 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.14% to 4,793.06 and the Dow Jones Industrial Average rising 0.25% to 36,488.63. This was the stock's third consecutive day of gains. Crown Castle International Corp. hit a new 52-week high, surpassing its previous peak of $206.84, which the company achieved on December 28th.

The stock outperformed some of its competitors Wednesday, as America Movil S.A.B. de C.V. Series A fell 0.74% to $21.60, SBA Communications Corp. (SBAC) rose 0.06% to $384.95, and American Tower REIT (AMT) rose 0.14% to $288.88. Trading volume (849,454) remained 786,805 below its 50-day average volume of 1.6 M.

Data source: Dow Jones Market Data, FactSet. Data compiled December 29, 2021.

-MarketWatch Automation

(END) Dow Jones Newswires

December 29, 2021 16:43 ET (21:43 GMT)